Squamous-cell carcinoma of the recipient's explanted lung
Yuan Zeng,Guilin Peng,Chao Yang,Mengyang Liu,Weixue Cui,Jinzhu Mao,Jianxing He,Xin Xu
DOI: https://doi.org/10.21037/tlcr-24-329
2024-09-29
Translational Lung Cancer Research
Abstract:Yuan Zeng 1,2,3,4# , Guilin Peng 1,2,3,4# , Chao Yang 1,2,3,4 , Mengyang Liu 1,2,3,4 , Weixue Cui 1,2,3,4 , Jinzhu Mao 1,2,3,4 , Jianxing He 1,2,3,4* , Xin Xu 1,2,3,4* 1 Department of Organ Transplantation, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; 2 Department of Thoracic Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; 3 Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory Disease, Guangzhou, China; 4 National Clinical Research Center for Respiratory Disease, Guangzhou, China # These authors contributed equally to this work as co-first authors. * These authors contributed equally to this work. Submitted Apr 16, 2024. Accepted for publication Aug 12, 2024. Published online Sep 27, 2024. doi: 10.21037/tlcr-24-329 A 66-year-old male patient with chronic obstructive pulmonary disease (COPD) underwent right lung transplantation 2 years ago. He has been a smoker for over 30 years, consuming approximately one pack of cigarettes daily. However, the donor of the transplanted lung had no history of smoking or malignant tumors. The patient undergoes a chest computed tomography (CT) scan every three months after surgery, and a chest CT scan one year later revealed a small solid nodule with a diameter of ~0.5 cm in the posterior basal segment of the right lower lung ( Figure 1A , blue arrow). The pulmonary nodule increased to a diameter of 1 cm after 3 months ( Figure 1B , blue arrow). After four and a half months the chest CT showed an enlarged pulmonary nodule ~2.5 cm in diameter with shallow lobulation, short hair spurs on the edge and the presence of pleural traction, suggesting peripheral lung cancer ( Figure 1C , blue arrow). Whole-body positron emission tomography/CT imaging revealed hypermetabolism in the right lower lung nodule ( Figure 2A , red arrow), with no hypermetabolic lymph nodes in the bilateral hilar or mediastinal regions, and no metastatic tumors throughout the body. Bronchoscopy examination identified no abnormal mucosa. Preoperative lung function examination showed diffusing capacity of the lung for carbon monoxide was 63% of the predicted value; forced expiratory volume in one second was 1.89 L, accounting for 61% of the predicted value. Pulmonary ventilation perfusion scanning indicated that the right lower lung perfusion accounted for 37% of the total, while ventilation accounted for 42%. The patient underwent right lower lobectomy and lymph node dissection of the hilum and mediastinum. The pathology results confirmed a diagnosis of squamous cell carcinoma ( Figure 2B ), with the pathological staging being T1N0M0, stage IA. Three days after surgery, the patient was admitted to the ICU for dyspnea and underwent invasive ventilation via endotracheal intubation. Patients with COPD secondary to smoking face a significantly elevated risk of lung cancer following lung transplantation, particularly single-lung transplantation, with lung cancer rarely originating from the donor lung (1). A case series study encompassing 520 lung transplant cases from a single center over 17 years revealed that 12 patients developed lung cancer, with only one instance being in the donor lung (2). For most solid organ transplant recipients who develop new cancer post-transplantation, research recommends reducing immunosuppressive therapy (3,4) instead of continuing with standard immunosuppressive therapy. During the perioperative period, the patient discontinued mycophenolate mofetil, lowered the target concentration of tacrolimus to approximately 8 ng/mL, and maintained a dosage of 15 mg prednisone acetate. Based on international expert consensus, patients should be cancer-free for at least 3–5 years prior to lung transplantation to minimize postoperative cancer recurrence and enhance the success rate of the procedure (5). However, for patients with early lung cancer, particularly those ineligible for conventional surgical removal due to pulmonary limitations or multifocal tumors, lung transplantation may be a viable option (4). The patient's preoperative lung function was compromised, with a disproportionately high ventilation perfusion ratio in the right lower lobe. Following right lower lobectomy, the pulmonary ventilation may fall short of the patient's requirements. Consequently, bilateral lung transplantation is another viable option worth considering. Funding: This study was supported by Guangdong Provincial Basic and Applied Basic Research Fund of China (grant No. 2020A1515110445); 2024-2026 Guangzhou High level Clinical Key Specialty Construction - Lung Transplantation. Provenance and Peer Review: This -Abstract Truncated-
oncology,respiratory system